{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:49:20Z","timestamp":1792014560468,"version":"4.4.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Natural Science Research Project of Jiangsu Higher Education Institutions of China","award":["24KJB520033"],"award-info":[{"award-number":["24KJB520033"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Model"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s00894-026-07010-0","type":"journal-article","created":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:11:50Z","timestamp":1792012310000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Force transfer in the glycosylated human CLEC-2\u2013podoplanin PLAG interface"],"prefix":"10.1007","volume":"32","author":[{"given":"Yao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han Ni","family":"Soe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7460-8981","authenticated-orcid":false,"given":"Zhipeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,14]]},"reference":[{"key":"7010_CR1","doi-asserted-by":"publisher","unstructured":"Abraham MJ, Murtola T, Schulz R, Pall S, Smith JC, Hess B, Lindahl E (2015) GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 1-2:19\u201325. https:\/\/doi.org\/10.1016\/j.softx.2015.06.001","DOI":"10.1016\/j.softx.2015.06.001"},{"issue":"2","key":"7010_CR2","doi-asserted-by":"publisher","first-page":"100160","DOI":"10.1016\/j.bvth.2026.100160","volume":"3","author":"JC Clark","year":"2026","unstructured":"Clark JC, Martin EM, Slater A, Calebiro D, Koszegi Z, Watson SP (2026) Receptor homodimerization significantly prolongs the lifetime of ligand-induced cross-linking of CLEC-2 but not GPVI. Blood Vessels Thromb Hemost 3(2):100160. https:\/\/doi.org\/10.1016\/j.bvth.2026.100160","journal-title":"Blood Vessels Thromb Hemost"},{"issue":"12","key":"7010_CR3","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1016\/j.str.2014.11.001","volume":"22","author":"H Fukuhara","year":"2014","unstructured":"Fukuhara H, Furukawa A, Maenaka K (2014) New binding face of C-type lectin-like domains. Structure 22(12):1694\u20131696. https:\/\/doi.org\/10.1016\/j.str.2014.11.001","journal-title":"Structure"},{"issue":"10","key":"7010_CR4","doi-asserted-by":"publisher","first-page":"3162","DOI":"10.1021\/ct200328p","volume":"7","author":"O Guvench","year":"2011","unstructured":"Guvench O, Mallajosyula SS, Raman EP, Hatcher E, Vanommeslaeghe K, Foster TJ, Jamison FW, MacKerell AD (2011) CHARMM additive all-atom force field for carbohydrate derivatives and its utility in polysaccharide and carbohydrate-protein modeling. J Chem Theor Computat 7(10):3162\u20133180. https:\/\/doi.org\/10.1021\/ct200328p","journal-title":"J Chem Theor Computat"},{"issue":"1","key":"7010_CR5","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/nmeth.4067","volume":"14","author":"J Huang","year":"2017","unstructured":"Huang J, Rauscher S, Nawrocki G, Ran T, Feig M, de Groot BL, Grubmuller H, MacKerell AD (2017) CHARMM36m: an improved force field for folded and intrinsically disordered proteins. Nat Methods 14(1):71\u201373. https:\/\/doi.org\/10.1038\/nmeth.4067","journal-title":"Nat Methods"},{"key":"7010_CR6","doi-asserted-by":"publisher","unstructured":"Izrailev S, Stepaniants S, Isralewitz B, Kosztin D, Lu H, Molnar F, Wriggers W, Schulten K (1999) Steered molecular dynamics. In: Computational molecular dynamics: Challenges, methods, ideas, vol\u00a04. Springer, pp 39\u201365. https:\/\/doi.org\/10.1007\/978-3-642-58360-5_2","DOI":"10.1007\/978-3-642-58360-5_2"},{"issue":"3","key":"7010_CR7","doi-asserted-by":"publisher","first-page":"e0152912","DOI":"10.1371\/journal.pone.0152912","volume":"11","author":"Y Kato","year":"2016","unstructured":"Kato Y, Ogasawara S, Oki H, Goichberg P, Honma R, Fujii Y, Kaneko MK (2016) LpMab-12 established by CasMab technology specifically detects sialylated O-glycan on Thr52 of platelet aggregation-stimulating domain of human podoplanin. PLoS ONE 11(3):e0152912. https:\/\/doi.org\/10.1371\/journal.pone.0152912","journal-title":"PLoS ONE"},{"key":"7010_CR8","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1016\/S0049-3848(12)70013-0","volume":"129","author":"KL Lowe","year":"2012","unstructured":"Lowe KL, Navarro-Nunez L, Watson SP (2012) Platelet CLEC-2 and podoplanin in cancer metastasis. Thromb Res 129:S30\u2013S37. https:\/\/doi.org\/10.1016\/S0049-3848(12)70013-0","journal-title":"Thromb Res"},{"key":"7010_CR9","doi-asserted-by":"publisher","unstructured":"Maqsood Z, Clark JC, Martin EM, Cheung YFH, Mor\u00e1n LA, Watson SET, Pike JA, Di Y, Poulter NS, Slater A, Lange BMH, Nieswandt B, Eble JA, Tomlinson MG, Owen DM, Stegner D, Bridge LJ, Wierling C, Watson SP (2022) Experimental validation of computerised models of clustering of\u00a0 platelet glycoprotein receptors that signal via tandem SH2 domain proteins. PLOS Computat Biol 18(11):e1010708. https:\/\/doi.org\/10.1371\/journal.pcbi.1010708","DOI":"10.1371\/journal.pcbi.1010708"},{"issue":"11","key":"7010_CR10","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1016\/j.bpj.2020.04.023","volume":"118","author":"AA Martyanov","year":"2020","unstructured":"Martyanov AA, Balabin FA, Dunster JL, Panteleev MA, Gibbins JM, Sveshnikova AN (2020) Control of platelet CLEC-2-mediated activation by receptor clustering and tyrosine kinase signaling. Biophys J 118(11):2641\u20132655. https:\/\/doi.org\/10.1016\/j.bpj.2020.04.023","journal-title":"Biophys J"},{"issue":"12","key":"7010_CR11","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1016\/j.str.2014.09.009","volume":"22","author":"M Nagae","year":"2014","unstructured":"Nagae M, Morita-Matsumoto K, Kato M, Kaneko MK, Kato Y, Yamaguchi Y (2014) A platform of C-type lectin-like receptor CLEC-2 for binding O-glycosylated podoplanin and nonglycosylated rhodocytin. Structure 22(12):1711\u20131721. https:\/\/doi.org\/10.1016\/j.str.2014.09.009","journal-title":"Structure"},{"issue":"1","key":"7010_CR12","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1186\/s12885-024-12194-w","volume":"24","author":"M Sheng","year":"2024","unstructured":"Sheng M, Sun R, Fu J, Lu G (2024) The podoplanin-CLEC-2 interaction promotes platelet-mediated melanoma pulmonary metastasis. BMC Cancer 24(1):399. https:\/\/doi.org\/10.1186\/s12885-024-12194-w","journal-title":"BMC Cancer"},{"issue":"1","key":"7010_CR13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12959-024-00594-8","volume":"22","author":"L Sun","year":"2024","unstructured":"Sun L, Wang Z, Liu Z, Mu G, Cui Y, Xiang Q (2024) C-type lectin-like receptor 2: roles and drug target. Thromb J 22(1):27. https:\/\/doi.org\/10.1186\/s12959-024-00594-8","journal-title":"Thromb J"},{"issue":"2","key":"7010_CR14","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/jb\/mvr079","volume":"150","author":"K Suzuki-Inoue","year":"2011","unstructured":"Suzuki-Inoue K (2011) Essential in vivo roles of the platelet activation receptor CLEC-2 in tumour metastasis, lymphangiogenesis and thrombus formation. J Biochem 150(2):127\u2013132. https:\/\/doi.org\/10.1093\/jb\/mvr079","journal-title":"J Biochem"},{"issue":"22","key":"7010_CR15","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1182\/blood.2019001388","volume":"134","author":"K Suzuki-Inoue","year":"2019","unstructured":"Suzuki-Inoue K (2019) Platelets and cancer-associated thrombosis: focusing on the platelet activation receptor CLEC-2 and podoplanin. Blood 134(22):1912\u20131918. https:\/\/doi.org\/10.1182\/blood.2019001388","journal-title":"Blood"},{"issue":"2","key":"7010_CR16","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/jth.13590","volume":"15","author":"K Suzuki-Inoue","year":"2017","unstructured":"Suzuki-Inoue K, Osada M, Ozaki Y (2017) Physiologic and pathophysiologic roles of interaction between C-type lectin-like receptor 2 and podoplanin: partners from in utero to adulthood. J Thromb Haemost 15(2):219\u2013229. https:\/\/doi.org\/10.1111\/jth.13590","journal-title":"J Thromb Haemost"},{"issue":"2","key":"7010_CR17","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s10555-017-9672-2","volume":"36","author":"A Takemoto","year":"2017","unstructured":"Takemoto A, Miyata K, Fujita N (2017) Platelet-activating factor podoplanin: from discovery to drug development. Cancer Metastasis Rev 36(2):225\u2013234. https:\/\/doi.org\/10.1007\/s10555-017-9672-2","journal-title":"Cancer Metastasis Rev"},{"issue":"17","key":"7010_CR18","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1182\/bloodadvances.2018016261","volume":"2","author":"N Tsukiji","year":"2018","unstructured":"Tsukiji N, Osada M, Sasaki T, Shirai T, Satoh K, Inoue O, Umetani N, Mochizuki C, Saito T, Kojima S, Shinmori H, Ozaki Y, Suzuki-Inoue K (2018) Cobalt hematoporphyrin inhibits CLEC-2-podoplanin interaction, tumor metastasis, and arterial\/venous thrombosis in mice. Blood Adv 2(17):2214\u20132225. https:\/\/doi.org\/10.1182\/bloodadvances.2018016261","journal-title":"Blood Adv"},{"issue":"3","key":"7010_CR19","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1055\/a-2211-5202","volume":"124","author":"N Watanabe","year":"2024","unstructured":"Watanabe N, Shinozaki Y, Ogiwara S, Miyagasako R, Sasaki A, Kato J, Suzuki Y, Fukunishi N, Okada Y, Saito T, Iida Y, Higashiseto M, Masuda H, Nagata E, Gotoh K, Amino M, Tsuji T, Morita S, Nakagawa Y, Hirayama N, Inokuchi S (2024) Diphenyl-tetrazol-propanamide derivatives act as dual-specific antagonists of platelet CLEC-2 and glycoprotein VI. Thromb Haemost 124(3):203\u2013222. https:\/\/doi.org\/10.1055\/a-2211-5202","journal-title":"Thromb Haemost"},{"issue":"46","key":"7010_CR20","doi-asserted-by":"publisher","first-page":"10988","DOI":"10.1021\/bi901427d","volume":"48","author":"AA Watson","year":"2009","unstructured":"Watson AA, Christou CM, James JR, Fenton-May AE, Moncayo GE, Mistry AR, Davis SJ, Gilbert RJC, Chakera A, O\u2019Callaghan CA (2009) The platelet receptor CLEC-2 is active as a dimer. Biochemistry 48(46):10988\u201310996. https:\/\/doi.org\/10.1021\/bi901427d","journal-title":"Biochemistry"}],"container-title":["Journal of Molecular Modeling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00894-026-07010-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00894-026-07010-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00894-026-07010-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:11:51Z","timestamp":1792012311000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00894-026-07010-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,14]]},"references-count":20,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["7010"],"URL":"https:\/\/doi.org\/10.1007\/s00894-026-07010-0","relation":{},"ISSN":["1610-2940","0948-5023"],"issn-type":[{"value":"1610-2940","type":"print"},{"value":"0948-5023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,14]]},"assertion":[{"value":"30 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable. This study used publicly available structural data and molecular simulations and did not involve human participants, human samples, or animals.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"421"}}